--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About SDGR20260220C20
Pharmaceutical
Schrodinger, Inc., was incorporated in California in August 1990 under the laws of the State of California. The company has developed a physics-based computing platform capable of predicting key properties of molecules with high precision, enabling faster discovery of high-quality, novel molecules for drug development and material applications at lower cost. Their software is used by biopharmaceuticals, industrial companies, academic institutions and government laboratories around the world. The company is a leading provider of computational software solutions for drug discovery. In addition to providing customers with a variety of software solutions, the company accelerates all stages of molecular discovery, design and optimization. They also leverage their platform and capabilities to cover a wide range of disease targets and indications through a range of collaborative and wholly-owned drug discovery programs.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
